42 completed, 7 unknown, 3 terminated, 2 withdrawn. 16 Phase 3, 14 Phase 2, 10 Not applicable, 9 Phase 4, 4 Phase 1.
Follow Formoterol: new trials by email Literature Review of Formoterol trials Research Report on Formoterol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| U-LABA/ICS Effects on Exercise Performance, Formoterol Symbicort, Formoterol, Placebo - Exercise Performance | Not applicable | Completed | Morten Hostrup, PhD | 20 | 2024-01-05 | 2024-08-13 |
| Beta2-adrenergic System and Training Training, Formoterol, Placebo - Healthy | Not applicable | Unknown | University of Copenhagen | 30 | 2020-11-10 | 2020-11-04 |
| Methacholine, Long-acting M-cholinolytic and beta2-agonist on the Activity of Beta-receptors in Healthy Volunteers Formoterol, Tiotropium Bromide, metacholine test - Health, Subjective, Hyperreactivity, Bronchial | Not applicable | Unknown | Federal State Budgetary Institution, Pulmonology Scientific Research Institute | 20 | 2019-04-24 | 2019-10-23 |
| Beta2-adrenergic Agonism and Muscle Remodelling Formoterol, Terbutaline, Placebo - Hypertrophy, Physiologic Hypertrophy | Not applicable | Unknown | Morten Hostrup, PhD | 72 | 2018-06-25 | 2020-03-25 |
| A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD Revefenacin, Placebo, Formoterol - Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Completed | Mylan Inc. | 122 | 2018-05-31 | 2022-02-24 |
| Efficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPD Tiotropium, Formoterol - Chronic Obstructive Pulmonary Disease | Not applicable | Unknown | Huashan Hospital | 120 | 2017-11-01 | 2017-10-19 |
| A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal Block Budesonide, Formoterol - Asthma, COPD | Phase 1 | Completed | Intech Biopharm Ltd. | 99 | 2017-06-19 | 2020-07-31 |
| Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment Tiotropium/Formoterol, Tiotropium, Formoterol - COPD | Phase 4 | Completed | Neutec Ar-Ge San ve Tic A.Ş | 84 | 2016-08-01 | 2020-06-16 |
| A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal Block Budesonide, Formoterol - Asthma, Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Completed | Intech Biopharm Ltd. | 99 | 2016-03-01 | 2016-08-01 |
| Small Airways Evaluation and Treatment beclomethasone, formoterol, budesonide - Pulmonary Disease，Chronic Obstructive; | Phase 4 | Unknown | Zhujiang Hospital | 90 | 2015-04-01 | 2015-08-18 |
| COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers Formoterol, Placebo - COPD Exacerbation | Not applicable | Completed | University of Tennessee Graduate School of Medicine | 7 | 2015-02-01 | 2019-03-19 |
| A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers Fluticasone/formoterol BAI, Formoterol, Fluticasone/formoterol PMDI without spacer - Asthma | Phase 1 | Completed | Mundipharma Research Limited | 125 | 2014-08-01 | 2015-09-28 |
| Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma Omalizumab, Budesonide, Formoterol - Severe IgE-mediated Asthma | Phase 4 | Terminated | Novartis Pharmaceuticals | 112 | 2013-11-11 | 2019-07-02 |
| A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPD Flutiform, Formoterol - Chronic Obstructive Pulmonary Disease | Phase 3 | Completed | Mundipharma Research Limited | 1767 | 2013-10-01 | 2018-10-24 |
| LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Budesonide, Placebo, Formoterol - Acute Respiratory Distress Syndrome (ARDS) | Phase 2 | Completed | Mayo Clinic | 61 | 2013-07-01 | 2016-09-05 |
| Effects of Particle Size in Small Airways Dysfunction Formoterol, Salmeterol - Asthma | Phase 4 | Completed | University of Dundee | 17 | 2013-07-01 | 2019-04-12 |
| The Effects of Atorvastatin Treatment in COPD Patients Atorvastatin, Formoterol, Lactose tablet - COPD | Phase 4 | Completed | Medical University of Bialystok | 18 | 2012-12-01 | 2013-04-23 |
| Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma Formoterol Fumarate in the Pressair DPI, Low Dose, Formoterol Fumarate in the Pressair DPI, High Dose, Foradil Aerolizer, Low Dose - Asthma | Phase 2 | Completed | AstraZeneca | 174 | 2012-06-01 | 2017-02-28 |
| The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD) QVA149, Placebo to tiotropium, Placebo to formoterol - Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Completed | Novartis Pharmaceuticals | 934 | 2012-05-01 | 2014-05-22 |
| Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Aclidinium/formoterol 400/12μg, Formoterol - Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Completed | AstraZeneca | 24 | 2012-01-01 | 2017-02-14 |
Showing 20 of 54. Sign in to see all of them.
Pulmonary Disease, Chronic Obstructive (25) · Asthma (22) · Respiratory Aspiration (2) · Airway Obstruction (1) · Asthma, Exercise-Induced (1) · Bronchial Hyperreactivity (1) · Bronchiolitis Obliterans (1) · Bronchitis, Chronic (1) · Cryptogenic Organizing Pneumonia (1) · Diabetes Mellitus, Type 1 (1) · Emphysema (1) · Hypertrophy (1) · Hypoglycemia (1) · Lung Diseases (1) · Lung Diseases, Interstitial (1)
AstraZeneca (11) · Novartis Pharmaceuticals (5) · Novartis (4) · Boehringer Ingelheim (3) · Chiesi Farmaceutici S.p.A. (3) · Brigham and Women's Hospital (2) · Intech Biopharm Ltd. (2) · Morten Hostrup, PhD (2) · Mundipharma Research Limited (2) · All India Institute of Medical Sciences (1) · Catholic University, Italy (1) · Federal State Budgetary Institution, Pulmonology Scientific Research Institute (1) · Huashan Hospital (1) · Johannes Gutenberg University Mainz (1) · Maisonneuve-Rosemont Hospital (1)
United States (11) · Germany (10) · Italy (7) · Poland (7) · Denmark (6) · Russia (6) · Spain (6) · Sweden (6) · United Kingdom (6) · South Africa (5) · Argentina (4) · Canada (4) · Czechia (4) · Hungary (4) · Romania (4)
Catherine Bonuccelli (4) · Elliot Israel, MD (2) · Esther Garcia, MD (2) · Agnieszka Brzozowska, MD, PhD (1) · Arvind Deva Manoharan, MBChB (1) · Brian Lipworth, MD (1) · Carlo Mereu, MD (1) · Elizabeth F Krakow, MD,CM, FRCPC (1) · Emir Festic, MD (1) · Gennaro D'Amato, MD (1) · Georgios Stratelis (1)
PMID 22329608, PMID 25045258, PMID 30077810, PMID 32848381, PMID 32943047, PMID 18804362, PMID 20522841, PMID 21145720, PMID 21227674, PMID 21397482, PMID 21689019, PMID 22003288, PMID 22206353, PMID 22235841, PMID 22394648, PMID 23731768, PMID 23907810, PMID 24524222, PMID 25716971, PMID 26153273, PMID 26220533, PMID 26505596, PMID 26762097, PMID 27039236, PMID 28064316, PMID 28240689, PMID 31397184, PMID 32270722, PMID 36472162
2008 (2), UL1RR024150 (1)